Investor Relations

Analyst coverage

Small Pharma is followed by the analysts listed below. Please note that any opinions, estimates or forecasts regarding Small Pharma’s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Small Pharma or its management. Small Pharma does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Canaccord Genuity
HCW logo
eight capital logo
Roth-Capital

A pipeline of short acting psychedelic programs

Our pipeline targets the development of treatments that provide fast-acting and long-lasting relief, and have in-clinic scalability potential to address the growing mental health crisis.

molecule

Years of R&D development

Number of granted patents

CAD$ raised in 2021

Leadership team

Chief Executive Officer

Chief Medical & Scientific Officer

Chief Operating Officer

Chief Innovation & IP Officer

Chief Manufacturing & Development Officer

Chief Financial Officer

Latest press releases

Events & conferences

About Small Pharma

We’re a biotechnology company researching and developing short-acting psychedelics with supportive therapy for mental health conditions.

Register for Company Updates


    Corporate Presentation

    Follow us: